RE: Newspaper headlines5 Apr 2021 11:39
JohnnyG505.
The Janssen jab'
A new single-dose vaccine has shown to be 66% effective against Covid-19, and offered complete protection against hospitalisation and death in trials.
However, there are signs the jab, made by Belgian pharmaceutical firm Janssen, is less effective against the new variant spreading in South Africa.
The Johnson & Johnson-owned company is looking at whether two doses will give stronger or longer-lasting protection.
It aims to make one billion doses this year.
The UK has ordered 30 million doses, the US 100 million and Canada 38 million.
UK Health Secretary Matt Han**** said if the jab was approved by Britain's Medicines and Healthcare Products Regulatory Agency (MHRA) it could "significantly bolster" the country's vaccine programme.